Health Condition 1: null- multiple verruca vulgaris
Conditions
Interventions
Intervention1: MMR vaccine: MMR vaccine which after reconstitution, in single dose of 0.5 ml will contain not less than
1000 CCID50 of Measles virus
5000 CCID50 of Mumps virus
1000 CCID50 of Rubell
Sponsors
Indian association of Dermatologists Venereologists and leprologists West Bengal
Eligibility
Inclusion criteria
Inclusion criteria: Male or female patients between 18 and 65 years of age (both inclusive). ii. Multiple viral warts >= 2 including genital warts iii. Patients who give their informed consent. iv. Patients not having received any anti-wart treatment in the past 4 weeks iv. Lack of viral diseases such as herpes and/or bacterial infections such as impetigo
Exclusion criteria
Exclusion criteria: Pregnant and lactating women. ii. Any evidence of immunosuppression (eg. HIV infection, organ transplantation, long term steroid or other non-steroidal immunosuppressive drug use etc.). iii. Any other systemic disease (eg. liver or kidney disorder). iv. Presence of ulcerated or inflamed wart(s). vi. Patients who participated in a clinical trial in the last 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| reduction in number and size of wartsTimepoint: at 4, 8 and 16 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| side effects of the two routes of vaccine.Timepoint: immediate and again at at 4,8 and 16 weeks | — |
Countries
India
Contacts
Public ContactAbanti Saha
Medical College, Kolkata
Outcome results
None listed